E
Emergent BioSolutions Inc. (EBS)
NYQ – Real vaqt narxi. Valyuta: USD
8.50
-0.45 (-5.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
8.50
-0.45 (-5.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Emergent BioSolutions Inc., biotexnologiya kompaniyasi, Amerika Qo'shma Shtatlari, Kanada va xalqaro miqyosda tasodifiy, qasddan sodir etilgan va tabiiy ravishda yuzaga keladigan jamoat salomatligi tahdidlari uchun tayyorgarlik va javob choralarini ta'minlaydi. Kompaniya tijorat mahsulotlari, inqirozni boshqarish mahsulotlari va boshqa daromadlar segmentlari orqali ishlaydi. Kompaniya ACAM2000, chechak va maymun chechagi uchun vaksina; Anthrax Immune Globulin Intravenous (ANTHRASIL), inhalatsion kuydirgini davolash uchun poliklonall antitel; Botulism Antitoxin Heptavalent (BAT), simptomatik botulizmni davolash uchun ot plazmasidan tayyorlangan antitoksin; BioThrax, kuydirgi uchun vaksina; CYFENDUS, Bacillus anthracis bilan aloqada bo'lgan yoki tasdiqlangan ta'siridan keyin kasallikning oldini olish uchun vaksina; Ebanga, Orthoebolavirus zairense tomonidan chaqirilgan infektsiyani davolash uchun monoklonal antitel; Raxibacumab in'ektsiyasi, Bacillus anthracis tomonidan chaqirilgan inhalatsion kuydirgini davolash va oldini olish uchun monoklonal antitel; TEMBEXA, kattalar va bolalarda variola virusi keltirib chiqaradigan chechak kasalligini davolash uchun og'iz orqali yuboriladigan antiviral; va CNJ-016, chechak vaksinatsiyasidan kelib chiqqan asoratlarni davolash uchun poliklonall antitelni taklif etadi. Shuningdek, kompaniya NARCAN va KLOXXADO burun sepuvchilari bilan opioidni haddan tashqari dozalashni aniqlash yoki gumon qilish holatlarida favqulodda davolashni taklif etadi. Mening kompaniyamiz dori moddasi va mahsulotini ishlab chiqarish, qadoqlash, shuningdek texnologiya transferi, jarayon, analitik ishlab chiqish va joy band qilish xizmatlarini o'z ichiga olgan shartnoma asosida ishlab chiqish va ishlab chiqarish xizmatlarini taqdim etadi. Emergent BioSolutions Inc. 1998 yilda tashkil etilgan va shtab-kvartirasi Maryland shtatining Gaithersburg shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Frank Vargo | VP & Treasurer |
| Mr. Joseph C. Papa Jr., M.B.A., R.Ph. | CEO, President & Director |
| Mr. Paul A. Williams | Senior Vice President of Products Business |
| Mr. Richard S. Lindahl M.B.A. | Executive VP & CFO |
| Mr. Simon C. Lowry M.D. | Chief Medical Officer and Head of Research & Development |
| Mr. William Hartzel | Senior Vice President of Manufacturing & Bioservices |
| Ms. Coleen Glessner | Executive Vice President of Quality, Ethics & Compliance |
| Ms. Jessica Perl | Senior VP, Corporate Secretary & General Counsel |
| Ms. Michelle Pepin | Senior VP & Chief Human Resource Officer |
| Ms. Stephanie Duatschek | Chief Global Strategy & Franchise Development Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-01 | 10-Q | ebs-20260331.htm |
| 2026-04-30 | S-8 | forms-8april2026.htm |
| 2026-04-30 | 8-K | ebs-20260430.htm |
| 2026-04-28 | DEFA14A | d72704ddefa14a.htm |
| 2026-04-27 | DEFA14A | d109259ddefa14a.htm |
| 2026-04-22 | DEFA14A | d53162ddefa14a.htm |
| 2026-04-17 | 8-K | ebs-20260416.htm |
| 2026-04-16 | DEFA14A | d129012ddefa14a.htm |
| 2026-03-20 | DEF 14A | ebs-20260320.htm |
| 2026-03-03 | 8-K | ebs-20260225.htm |